Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1978 Jul 29;2(6133):314–316. doi: 10.1136/bmj.2.6133.314

Prevalence of multiple sclerosis in north-east Scotland.

D I Shepherd, A W Downie
PMCID: PMC1606422  PMID: 687896

Abstract

An epidemiological study of multiple sclerosis (MS) in north-east Scotland was carried out based on data correct on 1 December 1970. The prevalence of MS was 127 cases/100 000 population, which is greater than in any other surveyed area with a comparable population. The disease was not spread homogeneously within the region, and in one district one in 400 people was affected. The geographical distributions of MS and the presence of HLA antigens A3 and B7,which are associated with the disease, are remarkably similar, and the prevalence of B7 in north-east Scotland is higher than elsewhere. This may partly explain the high prevalence of MS in this area, but the essential additional environmental factor remains to be established.

Full text

PDF
315

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beebe G. W., Kurtzke J. F., Kurland L. T., Auth T. L., Nagler B. Studies on the natural history of multiple sclerosis. 3. Epidemiologic analysis of the army experience in World War II. Neurology. 1967 Jan;17(1):1–17. doi: 10.1212/wnl.17.1.1. [DOI] [PubMed] [Google Scholar]
  2. CAMPBELL A. M. G., HERDAN G., TATLOW W. F. T., WHITTLE E. G. Lead in relation to disseminated sclerosis. Brain. 1950;73(1):52–71. doi: 10.1093/brain/73.1.52. [DOI] [PubMed] [Google Scholar]
  3. Compston D. A., Batchelor J. R., McDonald W. I. B-lymphocyte alloantigens associated with multiple sclerosis. Lancet. 1976 Dec 11;2(7998):1261–1265. doi: 10.1016/s0140-6736(76)92027-4. [DOI] [PubMed] [Google Scholar]
  4. DEACON W. E., ALEXANDER L., SIEDLER H. D., KURLAND L. T. Multiple sclerosis in a small New England community. N Engl J Med. 1959 Nov 19;261:1059–1061. doi: 10.1056/NEJM195911192612105. [DOI] [PubMed] [Google Scholar]
  5. Eastman R., Sheridan J., Poskanzer D. C. Multiple sclerosis clustering in a small Massachusetts community, with possible common exposure 23 years before onset. N Engl J Med. 1973 Oct 11;289(15):793–794. doi: 10.1056/NEJM197310112891507. [DOI] [PubMed] [Google Scholar]
  6. HARGREAVES E. R. Epidemiological studies in Cornwall. Proc R Soc Med. 1961 Mar;54:209–216. [PMC free article] [PubMed] [Google Scholar]
  7. Kurtzke J. F. An epidemiologic approach to multiple sclerosis. Arch Neurol. 1966 Feb;14(2):213–222. doi: 10.1001/archneur.1966.00470080097015. [DOI] [PubMed] [Google Scholar]
  8. Kurtzke J. F. An evaluation of the geographic distribution of multiple sclerosis. Acta Neurol Scand. 1966;42(Suppl):91+–91+. doi: 10.1111/j.1600-0404.1966.tb02008.x. [DOI] [PubMed] [Google Scholar]
  9. Kurtzke J. F. On statistical testing of prevalence studies. J Chronic Dis. 1966 Aug;19(8):909–922. doi: 10.1016/0021-9681(66)90007-5. [DOI] [PubMed] [Google Scholar]
  10. Kurtzke J. F. On the fine structure of the distribution of multiple sclerosis. Acta Neurol Scand. 1967;43(3):257–282. doi: 10.1111/j.1600-0404.1967.tb05733.x. [DOI] [PubMed] [Google Scholar]
  11. POSKANZER D. C., SCHAPIRA K., MILLER H. EPIDEMIOLOGY OF MULTIPLE SCLEROSIS IN THE COUNTIES OF NORTHUMBERLAND AND DURHAM. J Neurol Neurosurg Psychiatry. 1963 Aug;26:368–376. doi: 10.1136/jnnp.26.4.368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. PRATT R. T. C., COMPSTON N. D., McALPINE D. The familial incidence of disseminated sclerosis and its significance. Brain. 1951;74(2):191–232. doi: 10.1093/brain/74.2.191. [DOI] [PubMed] [Google Scholar]
  13. SUTHERLAND J. M. Observations on the prevalence of multiple sclerosis in Northern Scotland. Brain. 1956 Dec;79(4):635–654. doi: 10.1093/brain/79.4.635. [DOI] [PubMed] [Google Scholar]
  14. Stazio A., Paddison R. M., Kurland L. T. Multiple sclerosis in New Orleans, Louisiana, and Winnipeg, Manitoba, Canada: follow-up of a previous survey in New Orleans, and comparison between the patient populations in the two communities. J Chronic Dis. 1967 May;20(5):311–332. doi: 10.1016/0021-9681(67)90059-8. [DOI] [PubMed] [Google Scholar]
  15. Wikström J., Palo J. Studies on the clustering of multiple sclerosis in Finland I: Comparison between the domiciles and places of birth in selected subpopulations. Acta Neurol Scand. 1975 Feb;51(2):85–98. doi: 10.1111/j.1600-0404.1975.tb01362.x. [DOI] [PubMed] [Google Scholar]
  16. Wikström J. Studies on the clustering of multiple sclerosis in Finland II: microepidemiology in one high-risk county with special reference to familial cases. Acta Neurol Scand. 1975 Mar;51(3):173–183. doi: 10.1111/j.1600-0404.1975.tb07598.x. [DOI] [PubMed] [Google Scholar]
  17. Winchester R., Ebers G., Fu S. M., Espinosa L., Zabriskie J., Kunkel H. G. B-cell alloantigen Ag 7a in multiple sclerosis. Lancet. 1975 Oct 25;2(7939):814–814. doi: 10.1016/s0140-6736(75)80033-x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES